Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China flag China · Delayed Price · Currency is CNY
17.80
-0.05 (-0.28%)
Feb 24, 2026, 3:04 PM CST

SHE:002082 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
10,9193,9333,9155,4099,0828,470
Market Cap Growth
175.04%0.47%-27.62%-40.45%7.23%276.58%
Enterprise Value
11,8424,8994,8255,8709,91010,091
Last Close Price
17.856.436.288.5114.2713.02
PE Ratio
768.7770.9479.5658.0054.5529.73
Forward PE
-6.446.446.446.446.44
PS Ratio
7.872.732.543.034.700.62
PB Ratio
3.951.431.421.923.312.96
P/TBV Ratio
5.221.891.852.544.534.43
P/FCF Ratio
-170.18----
P/OCF Ratio
530.8032.72--411.2456.09
EV/Sales Ratio
8.543.393.133.295.130.74
EV/EBITDA Ratio
103.6028.7529.4217.4032.4818.51
EV/EBIT Ratio
-65.5268.7425.2447.0423.03
EV/FCF Ratio
-45.85211.95----
Debt / Equity Ratio
0.330.370.350.310.310.66
Debt / EBITDA Ratio
8.015.935.842.552.763.44
Debt / FCF Ratio
-44.49----
Net Debt / Equity Ratio
0.300.310.270.14-0.020.46
Net Debt / EBITDA Ratio
7.485.044.571.18-0.232.39
Net Debt / FCF Ratio
-3.2237.14-3.72-0.970.26-3.19
Asset Turnover
0.320.340.360.420.392.54
Inventory Turnover
3.283.613.413.131.8015.14
Quick Ratio
0.920.931.091.571.631.03
Current Ratio
1.471.371.451.941.921.65
Return on Equity (ROE)
0.37%1.64%0.94%2.65%5.75%10.27%
Return on Assets (ROA)
0.20%1.08%1.03%3.38%2.63%5.08%
Return on Invested Capital (ROIC)
0.17%1.61%1.84%5.81%2.75%9.50%
Return on Capital Employed (ROCE)
0.40%2.50%2.40%7.50%6.80%11.50%
Earnings Yield
0.13%1.41%1.26%1.72%1.83%3.36%
FCF Yield
-2.37%0.59%-5.15%-7.52%-2.90%-4.82%
Dividend Yield
--1.27%1.41%-1.54%
Payout Ratio
259.40%163.85%247.98%47.08%115.10%59.93%
Buyback Yield / Dilution
21.16%-0.15%1.06%-0.82%-1.73%-21.45%
Total Shareholder Return
21.16%-0.15%2.34%0.59%-1.73%-19.91%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.